Power Doppler ultrasonography with time-signal intensity curves in monitoring hepatocellular carcinoma and liver metastases after intralesional therapy;Il power Doppler e le curve intensità/tempo nel monitoraggio del trattamento intralesionale dell'epatocarcinoma e delle metastasi epatiche

Radiologia Medica

Volumn 114, Issue 1, 2009, Pages 32-41

  Farina, R ^a   Pennisi, F ^a   Mazzone, G ^a   Pennisi, M ^a   Riva, G ^a   Foti, P V ^a   Puglisi, C ^a   Ettorre, G C ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Contrast material; Focal hepatic lesions; Hepatocellular carcinoma; Metastasis; Power Doppler; Time intensity curves

Indexed keywords

ALCOHOL; SHU 508;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPPLER FLOWMETRY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; RADIOFREQUENCY ABLATION; TUMOR BIOPSY; TUMOR NECROSIS;

AGED; ALGORITHMS; BIOPSY; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; ETHANOL; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 62949089725     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-008-0324-z     Document Type: Article

References (24)

1. O. Seror G. N'Kontchou M. Tin Tin Htar 2006 Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost Gastroenterol Clin Biol 30 1265 1273
2. M. Omata R. Tateishi H. Yoshida 2004 Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation Gastroenterology 127 S159 S166
3. A. Dettmer T.D. Kirchhoff M. Gebel 2006 Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma World J Gastroenterol 12 3707 3715
4. C. Bartolozzi R. Lencioni N. Armillotta 1997 Trattamento combinato dell'epatocarcinoma con chemioembolizzazione e alcoolizzazione Radiol Med 94 19 23
5. G.P. Feltrin S. Savastano A. Marangon 1997 Risultati a lungo termine della chemioembolizzazione nell'epatocarcinoma Radiol Med 94 24 29
6. P. Abitabile U. Hartl J. Lange 2007 Radiofrequency ablation permits an effective treatment for colorectal liver metastasis Eur J Surg Oncol 33 67 71
7. D.H. Chow L.H. Sinn K.K. Ng 2006 Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study J Surg Oncol 94 565 571
8. R. Lencioni D. Cioni L. Crocetti 2005 Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation Radiology 234 961 967
9. H.X. Xu X.Y. Xie M.D. Lu 2004 Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation Clin Radiol 59 53 61
10. Y.S. Guan L. Sun X.P. Zhou 2004 Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up World J Gastroenterol 10 3543 3548
11. C. Bartolozzi R. Lencioni D. Caramella 1994 Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging AJR Am J Roentgenol 162 827 831
12. O. Catalano R. Lobianco M. Esposito 2001 Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns Abdom Imaging 26 375 383
13. C. Del Frate C. Zuiani V. Londero 2003 Comparing Levovist-enhanced pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging of hepatic metastases AJR Am J Roentgenol 180 1339 1346
14. T. Albrecht M.J. Blomley P.N. Burns 2003 Improved detection of hepatic metastases with pulse-inversion US during the liver specific phase of SHU 508A: multicenter study Radiology 227 361 370
15. T. Albrecht C.W. Hoffmann S.A. Schmitz 2001 Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases AJR Am J Roentgenol 176 1191 1198
16. C.K. Kim D. Choi H.K. Lim 2005 Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging Eur J Radiol 56 66 73
17. J.H. Youk J.M. Lee C.S. Kim 2003 Therapeutic response evaluation of malignant hepatic Masses treated by interventional procedures with contrast-enhanced agent detection imaging J Ultrasound Med 22 911 920
18. N. Lassau M. Lamuraglia I. Chawi 2005 Role of contrast-enhanced color Doppler ultrasonography and dynamic flow in the evaluation of hepatic tumors treated with radiofrequency Cancer Imaging 5 39 45
19. J.H. Youk J.M. Lee C.S. Kim 2003 Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging J Ultrasound Med 22 911 920
20. T. Kaneko O. Teshigawara H. Sugimoto 2005 Signal intensity of the liver parenchyma in microbubble contrast agent in the late liver phase reflects advanced fibrosis of the liver Liver Int 25 288 293
21. M. Hirota T. Kaneko H. Sugimoto 2005 Intrahepatic circulatory time analysis of an ultrasound contrast agent in liver cirrhosis Liver Int 25 337 342
22. H. Maruyama S. Matsutani H. Saisho 2004 Different behaviors of microbubbles in the liver: time-related quantitative analysis of two ultrasound contrast agents, Levovist and Definity Ultrasound Med Biol 30 1035 1040
23. T. Albrecht M.J. Blomley D.O. Cosgrove 1999 Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent Lancet 353 1579 1583
24. P. Ricci V. Cantisani L. Ballesio 2007 Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging Ultraschall Med 28 57 62